Newly recognized syndrome of metaphyseal undermodeling, spondylar dysplasia, and overgrowth: Report of two adolescents and a child
- 22 April 2004
- journal article
- case report
- Published by Wiley in American Journal of Medical Genetics Part A
- Vol. 128A (2) , 204-208
- https://doi.org/10.1002/ajmg.a.30030
Abstract
We report on a previously undescribed syndrome characterized by generalized skeletal alterations and overgrowth in three unrelated individuals: a boy who died at age 16 years, a 16‐year‐old girl, and a 15‐month‐old boy. The skeletal changes included bony overgrowth of the skull base, spondylar dysplasia, and undermodeling of the tubular bones. Bone age was accelerated in early childhood. Overgrowth, which was independent of GH–IGF axis, was of prenatal onset in the two boys, but postnatal in the girl. In the two adolescents, growth rate did not decline with age, and high‐dose estrogen therapy failed to induce physeal fusion. Their adolescent height reached +4∼+7 SD of the mean. Delayed puberty in the girl and cryptorchidism and hypospadias in the younger boy raised the possibility that hypogonadism is a syndromic constituent. Molecular analysis of IGF2, GPC3, and FGFR3 in the older boy yielded no abnormalities.Keywords
This publication has 10 references indexed in Scilit:
- Haploinsufficiency of NSD1 causes Sotos syndromeNature Genetics, 2002
- Bone Dysplasia Sclerosteosis Results from Loss of the SOST Gene Product, a Novel Cystine Knot–Containing ProteinAmerican Journal of Human Genetics, 2001
- Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)Human Molecular Genetics, 2001
- Defects in TCIRG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosisNature Genetics, 2000
- Genomic Organization of the Human Fibroblast Growth Factor Receptor 3 (FGFR3) Gene and Comparative Sequence Analysis with the MouseFgfr3GeneGenomics, 1997
- Somatic overgrowth associated with overexpression of insulin–like growth factor IINature Medicine, 1996
- Fibroblast Growth Factor Receptor 3 Is a Negative Regulator of Bone GrowthCell, 1996
- Mutations in GPC3, a glypican gene, cause the Simpson-Golabi-Behmel overgrowth syndromeNature Genetics, 1996
- Molecular analysis of a patient with Beckwith-Wiedemann syndrome, rhabdomyosarcoma and renal cell carcinomaJournal of Human Genetics, 1994
- Individualization of a syndrome with mental deficiency, macrocranium, peculiar facies, and cardiac and skeletal anomaliesClinical Genetics, 1982